Peter Jeffrey Snyder, Ph.D.

2008-2018 Neurology Warren Alpert Medical School of Brown University, Providence, RI, United States 
 2018- Department of Biomedical & Pharmaceutical Sciences The University of Rhode Island 
Neuropsychology, Neuropharmacology, Alzheimer's Disease, History of Neuroscience, Bioethics, Neurophysiology
"Peter J. Snyder"

Clinical neuropsychologist & neuroscientist, with initial specialty in epilepsy; Associate Prof. of Neurology, MCP & Hahnemann School of Medicine, Pittsburgh, 1994-1998; clinical drug development & discovery of novel biomarkers of neurodegenerative diseases progression - clinician at Pfizer Inc from 1998-2005; Professor of Psychology & Neurology, Univ. of Connecticut, 2005-2008; Visiting Professor, Yale Child Study Center, 2005 - present; Sr. Vice President & Chief Research Officer, Lifespan Hospitals System, Providence, RI, 2008 - 2018; Professor of Clinical Neuroscience (Neurology), Warren Alpert Medical School of Brown University, Providence, RI, 2008 - 2018. Vice President for Research & Professor of Biomedical and Pharmaceutical Sciences, The University of Rhode Island, Kingston, RI, 2018 - present. Scholar-in-Residence, The Rhode Island School of Design, Providence, RI., 2009 - present.

Mean distance: 15.92 (cluster 23)
Cross-listing: PsychTree - Alzheimer's Tree - History of History Tree


Sign in to add mentor
Jill B. Becker research assistant 1984-1986 University of Michigan
 (Undergraduate Honours Thesis Advisor)
Charles Butter research assistant 1984-1986 University of Michigan
 (Undergrad. advisor and Prof. for several courses)
William B. Barr grad student NYU School of Medicine
Lauren Julius Harris grad student 1986-1991 Michigan State
 (Major Professor & Doctoral Committee Chair)
Paul Fedio grad student 1991-1991 NIH
Robert M. Bilder post-doc 1992-1994 Albert Einstein
 (Clinical Neuroscience Post-Doc Fellow)
Zaven Khachaturian research scientist 1999-2005
 (Mentor to me, not by formal training, but through informal mentorship in science & AD)


Sign in to add collaborator
Harry  A. Whitaker collaborator 1995- Northern Michigan University
Paul T. Maruff collaborator 1999-
 (Most important collaborator and best friend)
Linda C. Mayes collaborator 2001- Yale School of Medicine
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Arthur E, Ravichandran S, Snyder PJ, et al. (2023) Retinal mid-peripheral capillary free zones are enlarged in cognitively unimpaired older adults at high risk for Alzheimer's disease. Alzheimer's Research & Therapy. 15: 172
Jutten RJ, Thompson L, Sikkes SAM, et al. (2022) A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach. Journal of Alzheimer's Disease : Jad
Arthur E, Alber J, Thompson LI, et al. (2021) OCTA reveals remodeling of the peripheral capillary free zones in normal aging. Scientific Reports. 11: 15593
Salloway S, Farlow M, McDade E, et al. (2021) A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine
Alber J, Arthur E, Goldfarb D, et al. (2021) The relationship between cerebral and retinal microbleeds in cerebral amyloid angiopathy (CAA): A pilot study. Journal of the Neurological Sciences. 423: 117383
Alber J, Arthur E, Sinoff S, et al. (2020) A recommended "minimum data set" framework for SD-OCT retinal image acquisition and analysis from the Atlas of Retinal Imaging in Alzheimer's Study (ARIAS). Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12119
Snyder PJ, Alber J, Alt C, et al. (2020) Retinal imaging in Alzheimer's and neurodegenerative diseases. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Alber J, Maruff P, Santos CY, et al. (2020) Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay interval. Alzheimer's Research & Therapy. 12: 31
Alber J, Goldfarb D, Thompson LI, et al. (2020) Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 229-243
Alber J, Arthur E, Thompson LI, et al. (2020) The Atlas of Retinal Imaging in Alzheimer’s Study (ARIAS): Study design and objectives Alzheimer's & Dementia. 16
See more...